Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature

被引:16
作者
Rutella, Sergio [1 ,2 ]
Vetrano, Stefania [3 ]
Correale, Carmen [3 ]
Graziani, Cristina [4 ]
Sturm, Andreas [5 ]
Spinelli, Antonino [6 ]
De Cristofaro, Raimondo [7 ]
Repici, Alessandro [3 ]
Malesci, Alberto [3 ]
Danese, Silvio [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Sch Med, Dept Hematol, I-00168 Rome, Italy
[2] IRCCS San Raffaele Pisana, Rome, Italy
[3] IRCCS Gastroenterol, Ist Clin Humanitas, Div Gastroenterol, Milan, Italy
[4] Univ Cattolica Sacro Cuore, Sch Med, Dept Gen Pathol, I-00168 Rome, Italy
[5] Univ Clin Charite, Div Med, Dept Gastroenterol, Berlin, Germany
[6] IRCCS Gastroenterol, Div Surg, Ist Clin Humanitas, Milan, Italy
[7] Univ Cattolica Sacro Cuore, Sch Med, Dept Med & Geriatr, I-00168 Rome, Italy
关键词
angiogenesis; tumour necrosis factor; inflammation; inflammatory bowel disease; ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PLATELETS; ULCERATIVE-COLITIS; CD40; LIGAND; T-CELLS; EXPRESSION; INTERLEUKIN-8; PATHWAY; THROMBOPOIETIN; PATHOGENESIS;
D O I
10.1111/j.1582-4934.2010.01033.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although angiogenesis is viewed as a fundamental component of inflammatory bowel disease (IBD) pathogenesis, we presently lack a thorough knowledge of the cell type(s) involved in its induction and maintenance in the inflamed intestinal mucosa. This study aimed to determine whether platelet (PLT) adhesion to inflamed intestinal endothelial cells of human origin may favour angiogenesis. Unstimulated or thrombin-activated human PLT were overlaid on resting or tumour necrosis factor (TNF)-alpha-treated human intestinal microvascular endothelial cells (HIMEC), in the presence or absence of blocking antibodies to either vascular cell adhesion molecule (VCAM)-1, intercellular adhesion molecule (ICAM)-1, integrin alpha(v)beta(3), tissue factor (TF) or fractalkine (FKN). PLT adhesion to HIMEC was evaluated by fluorescence microscopy, and release of angiogenic factors (VEGF and soluble CD40L) was measured by ELISA. A matrigel tubule formation assay was used to estimate PLT capacity to induce angiogenesis after co-culturing with HIMEC. TNF-alpha up-regulated ICAM-1, alpha(v)beta(3) and FKN expression on HIMEC. When thrombin-activated PLT were co-cultured with unstimulated HIMEC, PLT adhesion increased significantly, and this response was further enhanced by HIMEC activation with TNF-alpha. PLT adhesion to HIMEC was VCAM-1 and TF independent but ICAM-1, FKN and integrin alpha(v)beta(3) dependent. VEGF and sCD40L were undetectable in HIMEC cultures either before or after TNF-alpha stimulation. By contrast, VEGF and sCD40L release significantly increased when resting or activated PLT were co-cultured with TNF-alpha-pre-treated HIMEC. These effects were much more pronounced when PLT were derived from IBD patients. Importantly, thrombin-activated PLT promoted tubule formation in HIMEC, a functional estimate of their angiogenic potential. In conclusion, PLT adhesion to TNF-alpha-pre-treated HIMEC is mediated by ICAM-1, FKN and alpha(v)beta(3), and is associated with VEGF and sCD40L release. These findings suggest that inflamed HIMEC may recruit PLT which, upon release of pro-angiogenic factors, actively contribute to inflammation-induced angiogenesis.
引用
收藏
页码:625 / 634
页数:10
相关论文
共 50 条
  • [21] Hyaluronan in inflammatory bowel disease: Cross-linking inflammation and coagulation
    Petrey, Aaron C.
    de la Motte, Carol A.
    MATRIX BIOLOGY, 2019, 78-79 : 314 - 323
  • [22] Inflammatory bowel disease-associated intestinal fibrosis
    Park, Ji Min
    Kim, Jeongseok
    Lee, Yoo Jin
    Bae, Sung Uk
    Lee, Hye Won
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2023, 57 (01) : 60 - 66
  • [23] Inhibition of epithelial SHH signaling exerts a dual protective effect against inflammation and epithelial-mesenchymal transition in inflammatory bowel disease
    Ghorbaninejad, Mahsa
    Meyfour, Anna
    Maleknia, Samaneh
    Shahrokh, Shabnam
    Abdollahpour-Alitappeh, Meghdad
    Asadzadeh-Aghdaei, Hamid
    TOXICOLOGY IN VITRO, 2022, 82
  • [24] Bioelectrical Stimulation for the Reduction of Inflammation in Inflammatory Bowel Disease
    Marshall, Ryan
    Taylor, Ian
    Lahr, Christopher
    Abell, Thomas L.
    Espinoza, Ingrid
    Gupta, Nitin K.
    Gomez, Christian R.
    CLINICAL MEDICINE INSIGHTS-GASTROENTEROLOGY, 2015, 8 : 55 - 59
  • [25] Telomere dysfunction instigates inflammation in inflammatory bowel disease
    Chakravarti, Deepavali
    Lee, Rumi
    Multani, Asha S.
    Santoni, Andrea
    Keith, Zachery
    Hsu, Wen-Hao
    Chang, Kyle
    Reyes, Laura
    Rashid, Asif
    Wu, Chang-Jiun
    Li, Jun
    Zhang, Jiexin
    Shim, Hong Seok
    Chandra, Krishna
    Deng, Pingna
    Spring, Denise J.
    Nielsen, Ole Haagen
    Riis, Lene Buhl
    Mayigegowda, Kavya Kelagere
    Blutt, Sarah E.
    Zhang, Jianhua
    Younes, Mamoun
    DuPont, Andrew
    Thirumurthi, Selvi
    Vilar, Eduardo
    Estes, Mary K.
    Colla, Simona
    Shroyer, Noah F.
    DePinho, Ronald A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (29)
  • [26] Angiogenesis in inflammatory bowel disease
    Pousa, I. D.
    Mate, J.
    Gisbert, J. P.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (02) : 73 - 81
  • [27] Intestinal epithelium in inflammatory bowel disease
    Coskun, Mehmet
    FRONTIERS IN MEDICINE, 2014, 1
  • [28] Intestinal barrier in inflammatory bowel disease
    Antoni, Lena
    Nuding, Sabine
    Wehkamp, Jan
    Stange, Eduard F.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (05) : 1165 - 1179
  • [29] The Intestinal Microbiota in Inflammatory Bowel Disease
    Becker, Christoph
    Neurath, Markus F.
    Wirtz, Stefan
    ILAR JOURNAL, 2015, 56 (02) : 192 - 204
  • [30] Bone, inflammation, and inflammatory bowel disease
    Agrawal M.
    Arora S.
    Li J.
    Rahmani R.
    Sun L.
    Steinlauf A.F.
    Mechanick J.I.
    Zaidi M.
    Current Osteoporosis Reports, 2011, 9 (4) : 251 - 257